[1]
F. Petrelli, A. Caraffa, S. Scuri, I. Grappasonni, E. Magrini, and A. Cocchini, “The requirements for manufacturing highly active or sensitising drugs comparing Good Manufacturing Practices”, Acta Bio Med, vol. 90, no. 2, pp. 288-299, May 2019.